Think Tank on TROP-2 Therapy in NSCLC: A Look to the Future

Get up to date on emerging TROP-2–targeted antibody–drug conjugates for the treatment of advanced NSCLC with this comprehensive educational program, including expert-authored commentaries, a text module with a downloadable slideset capturing a panel discussion among 5 lung cancer experts, and a guided infographic on adverse event management with these agents.

Share

Program Content

Activities

Call to Action: TROP2 ADCs in Lung Cancer
Call to Action: Misperceptions on TROP2-Targeted Antibody–Drug Conjugates in Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 24, 2023

Expires: February 23, 2024

TROP2 ADC + IO in NSCLC
Combination Therapy With TROP2-Targeted Antibody–Drug Conjugates and Immunotherapy in Advanced/Metastatic NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2023

TROP2 ADCs for NSCLC 2023
Progress in the Development of Antibody–Drug Conjugates Targeting TROP-2 for Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2023

Activities

TROP-2 in NSCLC
Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2023

Expires: July 24, 2024

TROP-2 ADCs
Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2023

Activities

TROP2 ADC Toxicities
Managing the Toxicities of TROP2 Antibody–Drug Conjugates in Lung Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 24, 2023

TROP-2 ADC Toxicities Guided Infographic
Managing the Toxicities of TROP-2 Antibody‒Drug Conjugates in Lung Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2023

Faculty

cover img faculity

Hossein Borghaei, MS, DO

Professor and Chief, Thoracic Medical Oncology
The Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Department of Hematology and Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Yasushi Goto, MD, PhD

Assistant Chief 
Department of Thoracic Oncology 
National Cancer Center Hospital Japan
Tokyo, Japan 

cover img faculity

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Melissa L. Johnson, MD

Director, Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, Tennessee

cover img faculity

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Stephen V. Liu, MD

Associate Professor of Medicine
Director, Thoracic Oncology
Head, Developmental Therapeutics
Georgetown University
Washington, DC

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.